Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-08
2009-12-01
Andres, Janet L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S124000, C546S194000, C546S276400, C514S318000, C514S343000
Reexamination Certificate
active
07625896
ABSTRACT:
The present invention relates to the compounds of formula I:their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of such compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.
REFERENCES:
patent: 3991057 (1976-11-01), Delarge et al.
patent: 4018929 (1977-04-01), Delarge et al.
patent: 02098848 (2002-12-01), None
patent: WO 02/098848 (2002-12-01), None
patent: WO 03/035629 (2003-05-01), None
patent: WO 2004/048329 (2004-06-01), None
Hcaplus 138:24539.
Patani et. al., “Bioisosterism: A Rational Approach in Drug Design”, Chem. Rev., 96 (8), 3147 -3176, 1996. cr950066q S0009-2665(95)00066-5.
Patani et. al., “Bioisosterism: A Rational Approach in Drug Design”, Chem. Rev., 96 (8), 3147-3176, 1996, cr950066q S0009-2665 (95)0066-5.
Hcaplus 138:24539, “Preparation of benzoylsulfonamide and sulfonylbenzamidine angiogenesis inhibitors for use as antitumor agents”, Corbett et. al. WO 2002098848.
Suggitt et. al., “50 Years of Preclinical Anticancer Drug Screening: Empirical to Target-Driven Approaches”, vol. 11, 971-981, Feb. 1, 2005, Clinical Cancer Research, pp. 971-981.
Johnson et. al., “Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials”, British Journal of Cancer, (2001) 84 (10), 1424-1431.
Owa et al., Bioorg. Med. Chem. Lett., 12(16), pp. 2097-2100 (2002).
Corey et al., J. Org. Chem., 54, pp. 389-393 (1989).
Bastin et al., Organic Proc. Res. Dev., 4, pp. 427-435 (2000).
Delarge et al., Annales Pharmaceutiques Francaises, 41, pp. 55-60 (1983).
Kling Lothar
Reiff Ulrike
Schwaiger Manfred
Tiefenthaler Georg
von der Saal Wolfgang
Andres Janet L
Hoffman-La Roche Inc.
Johnston George W.
Robinson Binta M
Rocha-Tramaloni Patricia S.
LandOfFree
Pyridylsulfonamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridylsulfonamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridylsulfonamide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4065027